Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Buy
1,954
+45
+2% +$5.2K 0.17% 98
2025
Q4
$201K Buy
+1,909
New +$179K 0.15% 108
2025
Q1
Sell
-2,437
Closed -$242K 99
2024
Q4
$242K Hold
2,437
0.21% 78
2024
Q3
$277K Hold
2,437
0.25% 75
2024
Q2
$302K Sell
2,437
-420
-15% -$54.1K 0.28% 70
2024
Q1
$377K Sell
2,857
-97
-3% -$12K 0.33% 63
2023
Q4
$322K Buy
2,954
+200
+7% +$20.8K 0.31% 65
2023
Q3
$284K Buy
2,754
+92
+3% +$9.92K 0.31% 70
2023
Q2
$307K Buy
2,662
+379
+17% +$43K 0.32% 64
2023
Q1
$243K Sell
2,283
-80
-3% -$8.64K 0.28% 70
2022
Q4
$262K Hold
2,363
0.31% 70
2022
Q3
$204K Buy
+2,363
New +$211K 0.28% 76

Other funds holding MRK

HFG Advisors's MRK Position: Q1 2026 in Review

HFG Advisors increased its Merck (MRK) stake by 2.4% in Q1 2026, buying an estimated $5.2K and bringing the position to 1,954 shares worth $235K. The position accounts for 0.17% of the portfolio, ranked #98.

HFG Advisors first reported a position in MRK in Q3 2022 and has held it in 12 quarters since. The position peaked at $377K in Q1 2024. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • HFG Advisors held 1,954 shares of Merck worth $235K as of Q1 2026.
  • HFG Advisors bought 45 Merck shares in Q1 2026, an estimated $5.2K.
  • Merck made up 0.17% of HFG Advisors's portfolio in Q1 2026, its #98 holding.
  • HFG Advisors first reported a position in Merck in Q3 2022 and has held it in 12 quarters since.
  • HFG Advisors's Merck position peaked at $377K in Q1 2024.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HFG Advisors's 13F filing for Q1 2026, filed 8 May 2026.